FUSN
Federated Hermes’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,811,153
| Closed | -$230M | – | 2165 |
|
|
2024
Q1 | $230M | Sell |
10,811,153
-75,000
| -0.7% | -$1.6M | 0.53% | 36 |
|
|
2023
Q4 | $105M | Buy |
10,886,153
+202,364
| +2% | +$1.94M | 0.26% | 90 |
|
|
2023
Q3 | $27.8M | Buy |
10,683,789
+50,000
| +0.5% | +$130K | 0.07% | 295 |
|
|
2023
Q2 | $49.8M | Buy |
10,633,789
+4,784,689
| +82% | +$22.4M | 0.12% | 209 |
|
|
2023
Q1 | $22.1M | Buy |
5,849,100
+2,625,000
| +81% | +$9.9M | 0.06% | 363 |
|
|
2022
Q4 | $10.2M | Buy |
3,224,100
+50,000
| +2% | +$158K | 0.03% | 533 |
|
|
2022
Q3 | $9.56M | Buy |
3,174,100
+50,000
| +2% | +$151K | 0.03% | 542 |
|
|
2022
Q2 | $7.78M | Buy |
3,124,100
+69,063
| +2% | +$172K | 0.02% | 601 |
|
|
2022
Q1 | $23.7M | Buy |
3,055,037
+1,481,037
| +94% | +$11.5M | 0.05% | 403 |
|
|
2021
Q4 | $6.56M | Buy |
1,574,000
+120,110
| +8% | +$501K | 0.01% | 748 |
|
|
2021
Q3 | $11.5M | Buy |
1,453,890
+856,049
| +143% | +$6.78M | 0.02% | 610 |
|
|
2021
Q2 | $4.83M | Buy |
597,841
+32,841
| +6% | +$265K | 0.01% | 845 |
|
|
2021
Q1 | $6.06M | Buy |
565,000
+40,000
| +8% | +$429K | 0.01% | 789 |
|
|
2020
Q4 | $6.17M | Buy |
525,000
+15,000
| +3% | +$176K | 0.01% | 753 |
|
|
2020
Q3 | $6.13M | Buy |
510,000
+190,000
| +59% | +$2.28M | 0.01% | 688 |
|
|
2020
Q2 | $5.59M | Buy |
+320,000
| New | +$5.59M | 0.01% | 683 |
|